Division of Pulmonary, Critical Care and Sleep Medicine, Univ. of California, San Francisco, San Francisco, CA 94143-0111, USA.
Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L355-63. doi: 10.1152/ajplung.00069.2012. Epub 2012 Jun 15.
Sepsis and septic shock lead to considerable morbidity and mortality in developed and developing countries. Despite advances in understanding the innate immune events that lead to septic shock, molecular therapies based on these advances have failed to improve sepsis mortality. The clinical failure of laboratory-derived therapies may be, in part, due to the pleiotropic consequences of the acute inflammatory response, which is the focus of this review. A brisk response to infecting organism is essential for pathogen containment and eradication. However, systemic spread of inflammation beyond a single focus leads to organ injury and higher mortality. The primary goal of this article is to discuss recent animal- and human-based scientific advances in understanding the host response to infection and to highlight how these defense mechanisms can be locally beneficial but systemically detrimental. There are other factors that determine the severity of sepsis that are beyond the scope of this review, including the virulence of the pathogen and regulation by Toll-like receptors. Specifically, this review focuses on how the effector mechanisms of platelets, mast cells, neutrophil extracellular traps (NETs), and the endothelium participate in combating local infections yet can induce organ injury during systemic infection.
在发达国家和发展中国家,脓毒症和感染性休克导致了相当高的发病率和死亡率。尽管人们对导致感染性休克的先天免疫事件有了更多的了解,但基于这些进展的分子疗法未能改善脓毒症的死亡率。实验室衍生疗法的临床失败可能部分归因于急性炎症反应的多效性后果,这是本综述的重点。对感染病原体迅速做出反应对于病原体的控制和清除是至关重要的。然而,炎症的全身性扩散超过单一焦点会导致器官损伤和更高的死亡率。本文的主要目的是讨论最近在理解宿主对感染的反应方面的动物和人类的科学进展,并强调这些防御机制如何在局部有益但在全身有害。还有其他因素决定了脓毒症的严重程度,这些因素超出了本综述的范围,包括病原体的毒力和 Toll 样受体的调节。具体来说,本综述重点讨论了血小板、肥大细胞、中性粒细胞胞外陷阱(NETs)和内皮细胞的效应机制如何参与对抗局部感染,但在全身性感染时会导致器官损伤。